We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vaccines Advisory Committee Splits on Safety, Effectiveness of Sanofi’s Dengvaxia
Vaccines Advisory Committee Splits on Safety, Effectiveness of Sanofi’s Dengvaxia
An FDA advisory committee voted narrowly on Thursday against the effectiveness of Sanofi’s dengue virus vaccine and split evenly on its safety, except for children aged nine to 16.